Shawn Stetson
Nessuna posizione attualmente
Profilo
Shawn Stetson worked as a Senior Director & Controller at Quanterix Corp.
from 2021 to 2022.
Prior to that, he worked as a Controller at Novomer, Inc. from 2017 to 2019 and as a Controller at Nightstar Therapeutics Ltd.
in 2019.
Stetson graduated from Bowdoin College with a graduate degree and from Northeastern University with a graduate degree and an MBA.
Precedenti posizioni note di Shawn Stetson
| Società | Posizione | Fine |
|---|---|---|
| QUANTERIX CORPORATION | Director of Finance/CFO | 12/07/2021 |
| NIGHTSTAR THERAPEUTICS PLC | Comptroller/Controller/Auditor | 01/06/2019 |
Novomer, Inc.
 Novomer, Inc. Industrial SpecialtiesProcess Industries Novomer, Inc. manufactures biodegradable plastics, polymers, and other chemicals from renewable substances. It specializes in commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. The company was founded by Geoffrey William Coates, Anthony Romey Eisenhut and Scott D. Allen in 2004 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | 01/03/2019 |
Formazione di Shawn Stetson
| Bowdoin College | Graduate Degree |
| Northeastern University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| QUANTERIX CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Novomer, Inc.
Novomer, Inc. Industrial SpecialtiesProcess Industries Novomer, Inc. manufactures biodegradable plastics, polymers, and other chemicals from renewable substances. It specializes in commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. The company was founded by Geoffrey William Coates, Anthony Romey Eisenhut and Scott D. Allen in 2004 and is headquartered in Waltham, MA. | Process Industries |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Shawn Stetson
